NCT03904498View on ClinicalTrials.gov

COMT Inhibition Among Individuals With Comorbid AUD/ADHD

PHASE2RecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Alcohol Use DisorderAttention Deficit Hyperactivity Disorder
Interventions
DRUG

Tolcapone

Tolcapone 100 mg tablets

DRUG

Placebo

Placebo tablets

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Colorado, Denver

OTHER